• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过机械化学活化形成固体分散体提高难溶性药物的溶解度

Solubility Enhancement of a Poorly Water Soluble Drug by Forming Solid Dispersions using Mechanochemical Activation.

作者信息

Rojas-Oviedo I, Retchkiman-Corona B, Quirino-Barreda C T, Cárdenas J, Schabes-Retchkiman P S

机构信息

Programa de Maestría en Ciencias Farmacéuticas, División de Ciencias Biológicas y de la Salud. Universidad Autónoma Metropolitana-Xochimilco. Calzada del Hueso 1100, Col. Villa Quietud. C.P. 04960 México, D.F., Mexico.

出版信息

Indian J Pharm Sci. 2012 Nov;74(6):505-11. doi: 10.4103/0250-474X.110576.

DOI:10.4103/0250-474X.110576
PMID:23798775
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3687919/
Abstract

Mechanochemical activation is a practical cogrinding operation used to obtain a solid dispersion of a poorly water soluble drug through changes in the solid state molecular aggregation of drug-carrier mixtures and the formation of noncovalent interactions (hydrogen bonds) between two crystalline solids such as a soluble carrier, lactose, and a poorly soluble drug, indomethacin, in order to improve its solubility and dissolution rate. Samples of indomethacin and a physical mixture with a weight ratio of 1:1 of indomethacin and lactose were ground using a high speed vibrating ball mill. Particle size was determined by electron microscopy, the reduction of crystallinity was determined by calorimetry and transmission electron microscopy, infrared spectroscopy was used to find evidence of any interactions between the drug and the carrier and the determination of apparent solubility allowed for the corroboration of changes in solubility. Before grinding, scanning electron microscopy showed the drug and lactose to have an average particle size of around 50 and 30 μm, respectively. After high speed grinding, indomethacin and the mixture had a reduced average particle size of around 5 and 2 μm, respectively, showing a morphological change. The ground mixture produced a solid dispersion that had a loss of crystallinity that reached 81% after 30 min of grinding while the drug solubility of indomethacin within the solid dispersion increased by 2.76 fold as compared to the pure drug. Drug activation due to hydrogen bonds between the carboxylic group of the drug and the hydroxyl group of lactose as well as the decrease in crystallinity of the solid dispersion and the reduction of the particle size led to a better water solubility of indomethacin.

摘要

机械化学活化是一种实际的共研磨操作,用于通过改变药物-载体混合物的固态分子聚集以及在两种结晶固体(如可溶性载体乳糖和难溶性药物吲哚美辛)之间形成非共价相互作用(氢键)来获得难溶性药物的固体分散体,以提高其溶解度和溶出速率。使用高速振动球磨机研磨吲哚美辛样品以及吲哚美辛与乳糖重量比为1:1的物理混合物。通过电子显微镜测定粒径,通过量热法和透射电子显微镜测定结晶度的降低,使用红外光谱寻找药物与载体之间任何相互作用的证据,并通过测定表观溶解度来证实溶解度的变化。研磨前,扫描电子显微镜显示药物和乳糖的平均粒径分别约为50和30μm。高速研磨后,吲哚美辛和混合物的平均粒径分别减小至约5和2μm,呈现出形态变化。研磨后的混合物形成了一种固体分散体,研磨30分钟后结晶度损失达到81%,而固体分散体中吲哚美辛的药物溶解度与纯药物相比增加了2.76倍。药物羧基与乳糖羟基之间的氢键导致的药物活化以及固体分散体结晶度的降低和粒径的减小,使得吲哚美辛具有更好的水溶性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/40ee7aa40ec1/IJPhS-74-505-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/1008d7e59edc/IJPhS-74-505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/5d5e0f36d0fd/IJPhS-74-505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/29f76182a12b/IJPhS-74-505-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/984a5fa5bbb9/IJPhS-74-505-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/a0b793c615ce/IJPhS-74-505-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/40ee7aa40ec1/IJPhS-74-505-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/1008d7e59edc/IJPhS-74-505-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/5d5e0f36d0fd/IJPhS-74-505-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/29f76182a12b/IJPhS-74-505-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/984a5fa5bbb9/IJPhS-74-505-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/a0b793c615ce/IJPhS-74-505-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9cca/3687919/40ee7aa40ec1/IJPhS-74-505-g006.jpg

相似文献

1
Solubility Enhancement of a Poorly Water Soluble Drug by Forming Solid Dispersions using Mechanochemical Activation.通过机械化学活化形成固体分散体提高难溶性药物的溶解度
Indian J Pharm Sci. 2012 Nov;74(6):505-11. doi: 10.4103/0250-474X.110576.
2
Dissolution properties and physical characterization of telmisartan-chitosan solid dispersions prepared by mechanochemical activation.采用机械化学活化法制备替米沙坦-壳聚糖固体分散体的溶解性能及物理特性研究。
AAPS PharmSciTech. 2013 Jun;14(2):541-50. doi: 10.1208/s12249-013-9937-1. Epub 2013 Feb 21.
3
Dissolution Improvement of Atorvastatin Calcium using Modified Locust Bean Gum by the Solid Dispersion Technique.采用固体分散技术用改性刺槐豆胶改善阿托伐他汀钙的溶出度
Sci Pharm. 2013 Dec 9;82(1):177-91. doi: 10.3797/scipharm.1301-23. Print 2014 Jan-Mar.
4
To enhance dissolution rate of poorly water-soluble drugs: glucosamine hydrochloride as a potential carrier in solid dispersion formulations.提高难溶性药物的溶出速率:盐酸氨基葡萄糖作为固体分散体制剂中的潜在载体。
Colloids Surf B Biointerfaces. 2010 Mar 1;76(1):170-8. doi: 10.1016/j.colsurfb.2009.10.030. Epub 2009 Nov 11.
5
Preparation and in-vitro evaluation of indomethacin nanoparticles.制备及吲哚美辛纳米粒的体外评价。
Daru. 2010;18(3):185-92.
6
Evaluation of modified gum karaya as carrier for the dissolution enhancement of poorly water-soluble drug nimodipine.评价改性刺梧桐树胶作为载体对难溶性药物尼莫地平溶出度的增强作用。
Int J Pharm. 2002 Mar 2;234(1-2):1-17. doi: 10.1016/s0378-5173(01)00925-5.
7
Physicochemical properties of tadalafil solid dispersions - Impact of polymer on the apparent solubility and dissolution rate of tadalafil.他达拉非固体分散体的物理化学性质——聚合物对他达拉非表观溶解度和溶出速率的影响。
Eur J Pharm Biopharm. 2015 Aug;94:106-15. doi: 10.1016/j.ejpb.2015.04.031. Epub 2015 May 19.
8
Use of the co-grinding method to enhance the dissolution behavior of a poorly water-soluble drug: generation of solvent-free drug-polymer solid dispersions.采用共研磨法提高难溶性药物的溶出行为:制备无溶剂药物-聚合物固体分散体
Chem Pharm Bull (Tokyo). 2012;60(7):837-45. doi: 10.1248/cpb.c12-00034.
9
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.吲哚美辛与聚乙二醇6000、聚山梨酯52、乳糖、山梨醇、糊精和丙烯酸树脂E100固体分散体的物理化学表征
Drug Dev Ind Pharm. 2004 Mar;30(3):303-17. doi: 10.1081/ddc-120030426.
10
Cryo-TEM and AFM Observation of the Time-Dependent Evolution of Amorphous Probucol Nanoparticles Formed by the Aqueous Dispersion of Ternary Solid Dispersions.冷冻透射电子显微镜和原子力显微镜观察三元固体分散体水分散体中无定形普罗布考纳米颗粒的时变演变。
Mol Pharm. 2019 May 6;16(5):2184-2198. doi: 10.1021/acs.molpharmaceut.9b00158. Epub 2019 Apr 9.

引用本文的文献

1
Development, Characterization, and Cellular Toxicity Evaluation of Solid Dispersion-Loaded Hydrogel Based on Indomethacin.基于吲哚美辛的固体分散体负载水凝胶的制备、表征及细胞毒性评价
Polymers (Basel). 2024 Jul 30;16(15):2174. doi: 10.3390/polym16152174.

本文引用的文献

1
Drug mechanochemical activation.药物机械化学激活。
J Pharm Sci. 2009 Nov;98(11):3961-86. doi: 10.1002/jps.21733.
2
Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs.固体分散体作为提高难溶性药物口服生物利用度的策略。
Drug Discov Today. 2007 Dec;12(23-24):1068-75. doi: 10.1016/j.drudis.2007.09.005. Epub 2007 Oct 30.
3
Crystal engineering of active pharmaceutical ingredients to improve solubility and dissolution rates.通过晶体工程优化活性药物成分以提高溶解度和溶出速率。
Adv Drug Deliv Rev. 2007 Jul 30;59(7):617-30. doi: 10.1016/j.addr.2007.05.011. Epub 2007 May 29.
4
Anti-inflammatory agent indomethacin reduces invasion and alters metabolism in a human breast cancer cell line.抗炎药物吲哚美辛可降低人乳腺癌细胞系的侵袭能力并改变其代谢。
Neoplasia. 2007 Mar;9(3):222-35. doi: 10.1593/neo.06673.
5
Preparation of All-Trans Retinoic Acid nanosuspensions using a modified precipitation method.采用改良沉淀法制备全反式维甲酸纳米混悬液。
Drug Dev Ind Pharm. 2006 Aug;32(7):857-63. doi: 10.1080/03639040500534184.
6
Solubilization of two structurally related anticancer drugs: XK-469 and PPA.两种结构相关的抗癌药物:XK - 469和PPA的增溶作用。
J Pharm Sci. 2006 Jan;95(1):97-107. doi: 10.1002/jps.20500.
7
Formation and characterization of porous indomethacin-PVP coprecipitates prepared using solvent-free supercritical fluid processing.采用无溶剂超临界流体工艺制备的多孔吲哚美辛 - 聚乙烯吡咯烷酮共沉淀物的形成与表征
J Pharm Sci. 2005 Dec;94(12):2583-90. doi: 10.1002/jps.20474.
8
Release of indomethacin from ultrasound dry granules containing lactose-based excipients.
J Control Release. 2005 Jan 20;102(1):39-47. doi: 10.1016/j.jconrel.2004.09.017.
9
Physicochemical characterization of solid dispersions of indomethacin with PEG 6000, Myrj 52, lactose, sorbitol, dextrin, and Eudragit E100.吲哚美辛与聚乙二醇6000、聚山梨酯52、乳糖、山梨醇、糊精和丙烯酸树脂E100固体分散体的物理化学表征
Drug Dev Ind Pharm. 2004 Mar;30(3):303-17. doi: 10.1081/ddc-120030426.
10
A novel particle engineering technology to enhance dissolution of poorly water soluble drugs: spray-freezing into liquid.一种用于提高难溶性药物溶出度的新型颗粒工程技术:喷雾冷冻成液。
Eur J Pharm Biopharm. 2002 Nov;54(3):271-80. doi: 10.1016/s0939-6411(02)00063-2.